EGFR and gastric cancer: Evidence also shows that miR-125a-5p may be as a potential tumor-suppressor in gastric cancer [44, 45], and acts as an inhibitor to epidermal growth factor receptor signaling to block migration and invasion of lung cancer cells [46].